Noah L. Rosenberg

Insider Reports History

Location
Plymouth, MI
Signature
/s/ Jayson Rieger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Noah L. Rosenberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Chief Medical Officer Common Stock 47,614 $426,621 $8.96 17 Aug 2021 Direct
Verrica Pharmaceuticals Inc. CMO Common Stock 2,357 $9,999 $4.24 25 Nov 2025 Direct
Verrica Pharmaceuticals Inc. CMO Employee Stock Option (right to buy) 325,000 24 Mar 2025 Direct
Verrica Pharmaceuticals Inc. CMO Series C Warrant (right to buy) 589 25 Nov 2025 Direct

Insider Reports Filed by Noah L. Rosenberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRCA Verrica Pharmaceuticals Inc. 25 Nov 2025 2 +$10,000 4 CMO 25 Nov 2025, 19:00
VRCA Verrica Pharmaceuticals Inc. 24 Mar 2025 1 $0 4 CMO 26 Mar 2025, 07:10
VRCA Verrica Pharmaceuticals Inc. 24 Mar 2025 0 $0 3 CMO 26 Mar 2025, 07:08
TVTX Travere Therapeutics, Inc. 13 Aug 2021 2 -$24,085 4 Chief Medical Officer 17 Aug 2021, 19:39
TVTX Travere Therapeutics, Inc. 28 Jul 2021 1 -$17,262 4 Chief Medical Officer 29 Jul 2021, 16:09
TVTX Travere Therapeutics, Inc. 11 May 2021 2 -$14,475 4 Chief Medical Officer 13 May 2021, 16:11